Summary
The publisher's Medical Devices sector report, “Hepatitis Viruses Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hepatitis Viruses Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Hepatitis Viruses Rapid Tests & POC comprises of rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for Hepatitis B and C.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Reasons to Buy
The report enables you to -
The publisher's Medical Devices sector report, “Hepatitis Viruses Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hepatitis Viruses Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Hepatitis Viruses Rapid Tests & POC comprises of rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for Hepatitis B and C.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Hepatitis Viruses Rapid Tests & POC under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hepatitis Viruses Rapid Tests & POC and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hepatitis Viruses Rapid Tests & POC under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Hepatitis Viruses Rapid Tests & POC - Pipeline Products under Development by Companies
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Diagnostics
- Akers Biosciences Inc
- Alere Inc
- Arkray Inc
- Atomo Diagnostics Ltd
- Biocartis Group NV
- bioLytical Laboratories Inc
- Biosurfit, SA
- Biotech Consortium India Ltd
- Biotech Resources Aust Pty Ltd
- Blink AG
- Boston University
- Cepheid Inc
- Chembio Diagnostic Systems Inc
- ChipCare Corp
- Correlia Biosystems, Inc.
- CoSara Diagnostics Pvt Ltd
- Daktari Diagnostics, Inc.
- DCN Diagnostics
- Diagnostics For All Inc
- Diagnostics for the Real World Ltd
- Fast Track Diagnostics Ltd
- Group K Diagnostics
- ImmunoScience Inc
- MedMira Inc
- Micronics Inc
- Mologic Ltd
- NanoComposix Inc
- NanoRepro AG
- NOWDiagnostics Inc
- Quidel Corp
- SLS Cell Cure Technologies Pty Ltd
- University of California Irvine
- Wave 80 Biosciences Inc
- Xagenic Inc